Pfizer Gets Abuse-Deterrent Claim on One Pain Drug, Then Drops Development of Another
This article was originally published in RPM Report
Executive Summary
Pfizer got its first abuse-deterrent claim for its pain therapy Embeda. But it has also ended an agreement to develop another potential abuse-deterrent pain drug.